Chemoinformaics analysis of N-P-COUMAROYL-GLUTAMIC-ACID
| Molecular Weight | 293.275 | nRot | 7 |
| Heavy Atom Molecular Weight | 278.155 | nRig | 10 |
| Exact Molecular Weight | 293.09 | nRing | 1 |
| Solubility: LogS | -1.269 | nHRing | 0 |
| Solubility: LogP | 0.387 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 39.2939 |
| nHD | 4 | BPOL | 18.2221 |
| QED | 0.65 |
| Synth | 2.532 |
| Natural Product Likeliness | 0.215 |
| NR-PPAR-gamma | 0.345 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.013 |
| HIA | 0.842 |
| CACO-2 | -6.043 |
| MDCK | 0.00000675 |
| BBB | 0.05 |
| PPB | 0.684722 |
| VDSS | 0.328 |
| FU | 0.254667 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.037 |
| CYP2c9-inh | 0.029 |
| CYP2c9-sub | 0.693 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.16 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.021 |
| CL | 1.754 |
| T12 | 0.906 |
| hERG | 0.017 |
| Ames | 0.014 |
| ROA | 0.018 |
| SkinSen | 0.129 |
| Carcinogencity | 0.178 |
| EI | 0.273 |
| Respiratory | 0.021 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.831127 |